Vivos Therapeutics earnings were -$11.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest VVOS earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$2.8M, up 8.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VVOS reported annual earnings of -$11.1M, with -18% growth. The next VVOS earnings date is May 12, 2025.
What were Vivos Therapeutics's earnings last quarter?
On VVOS's earnings call on Invalid Date, Vivos Therapeutics (NASDAQ: VVOS) reported Q4 2024 earnings per share (EPS) of -$0.28, up 90.82% year over year. Total VVOS earnings for the quarter were -$2.83 million. In the same quarter last year, Vivos Therapeutics's earnings per share (EPS) was -$3.05.
The next VVOS earnings call is Invalid Date. Add VVOS to your watchlist to be reminded of Vivos Therapeutics's next earnings date.
What was VVOS's earnings growth in the past year?
As of Vivos Therapeutics's earnings date in Invalid Date, Vivos Therapeutics's earnings has grown year over year. VVOS earnings in the past year totalled -$11.14 million.
Is Vivos Therapeutics profitable or losing money?
As of the last Vivos Therapeutics earnings report, Vivos Therapeutics is currently losing money. Vivos Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$11.14 million, a 18.02% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.